HIGHLIGHTS
- What: This study investigated the role of Mucin 19 (MUC19) a member of the mucin family that has been implicated in cancer progression. The authors aimed to assess whether mutations are associated with a worse prognosis in patients with GBM and explore its potential as a target. version 1 view 1. This study provides significant insights into the genetic alterations associated with glioblastoma multiforme (GBM) mortality and highlights potential therapeutic targets, mainly focusing on mucin genes.
- Who: Glioblastoma multiforme and collaborators from the Department of Biological Science, The University of Suwon, Hwaseong-si, Gyeonggi-do . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.